---
title: How I diagnose and treat organizing pneumonia in hematopoietic cell transplant
  recipients
date: '2024-06-12'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38864640/?utm_source=curl&utm_medium=rss&utm_campaign=journals&utm_content=7603509&fc=None&ff=20240612181555&v=2.18.0.post9+e462414
source: Blood
description: Organizing pneumonia (OP) is a known non-infectious pulmonary complication
  following allogeneic hematopoietic cell transplant (HCT) and represents a significant
  risk factor for non-relapse mortality in HCT recipients. Unlike bronchiolitis obliterans
  syndrome, it is not universally acknowledged as a distinctive pulmonary manifestation
  of chronic-graft-versus-host disease (cGVHD) and therefore, its diagnostic criteria
  and management approach is lacking. Given it shared similar clinical ...
disable_comments: true
---
Organizing pneumonia (OP) is a known non-infectious pulmonary complication following allogeneic hematopoietic cell transplant (HCT) and represents a significant risk factor for non-relapse mortality in HCT recipients. Unlike bronchiolitis obliterans syndrome, it is not universally acknowledged as a distinctive pulmonary manifestation of chronic-graft-versus-host disease (cGVHD) and therefore, its diagnostic criteria and management approach is lacking. Given it shared similar clinical ...